# FDA Inspection 1181413 - QPS Bioserve India Pvt. Limited - September 23, 2022

Source: https://www.keypedia.com/records/fda_inspections/qps-bioserve-india-pvt-limited/319b1587-4e39-491b-abce-512beb4d0638
Source feed: FDA_Inspections

> FDA Inspection 1181413 for QPS Bioserve India Pvt. Limited on September 23, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1181413
- Company Name: QPS Bioserve India Pvt. Limited
- Inspection Date: 2022-09-23
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1310708 - 2026-02-06](https://www.keypedia.com/records/fda_inspections/qps-bioserve-india-pvt-limited/ea9fa097-debb-4aed-987e-265df25b52f5)
- [FDA Inspection 1310708 - 2026-02-06](https://www.keypedia.com/records/fda_inspections/qps-bioserve-india-pvt-limited/e9c9e740-dcc2-4678-a9c0-fdc26aa93405)

Company: https://www.keypedia.com/companies/qps-bioserve-india-pvt-limited/4034c2d3-5414-48d2-b565-f4983ac2ab03

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c